Merck & Co., Inc. — Director's Dealing 2017

Dec 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-12-15

Reporting Person: Schechter Adam H (EVP & Pres-Global Human Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-15	Common Stock	G	750.0000	$0.0000	Disposed	113373.9747	Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.